Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
2.
Tech Coloproctol ; 27(6): 481-490, 2023 06.
Article in English | MEDLINE | ID: mdl-37160596

ABSTRACT

PURPOSE: To evaluate the potential benefits associated with the short-term (6 months) treatment with transanal irrigation (TAI) in patients suffering from functional constipation (FC), functional fecal incontinence (FI), and low anterior resection syndrome (LARS). METHODS: A multicenter observational study (12 centers; 369 patients) was conducted to assess the following primary and secondary objectives: to evaluate the level of satisfaction regarding bowel control and quality of life (QoL); to evaluate bowel symptoms severity and dropout frequency and reason. To this aim, validated questionnaires were provided to the patients at baseline (T0) and after 6 months of TAI treatment (T6) performed with the medical device Peristeen® Plus (Coloplast A/S, Denmark). Statistical analyses were conducted to compare the outcomes obtained at T0 and T6. RESULTS: A 6-month treatment with TAI enabled a statistically significant (p < 0.05) improvement of QoL scores, satisfaction scores regarding bowel control, and severity indexes of disorder-related symptoms in patients suffering from FC, FI, and LARS. Globally, 8.0% of patients discontinued the treatment after 6 months as a result of occurrence of symptoms (2.4%) or other justifications (3.8%) such as personal reasons. None of the dropouts were due to treatment inefficacy. CONCLUSION: Results of the present study suggest that short-term TAI treatment is beneficial for patients suffering from functional bowel disorders and LARS. Future analysis of prospective data will focus on the clinical outcomes associated with the long-term use (up to 24 months) of TAI when dealing with these types of medical conditions.


Subject(s)
Irritable Bowel Syndrome , Rectal Neoplasms , Humans , Quality of Life , Postoperative Complications , Prospective Studies , Irritable Bowel Syndrome/therapy , Low Anterior Resection Syndrome
3.
G Chir ; 40(5): 445-449, 2019.
Article in English | MEDLINE | ID: mdl-32003728

ABSTRACT

Negative Pressure Wound Therapy with instillation therapy and dwelling time (NPWTid) represents a good tool to treat severely infected non-healing wounds. This topical treatment consists of negative pressure and retrograde instillation of antiseptic/antibiotic Romasolutions into the wound surface, to promote cleansing and consequently the healing process. We reported our initial experience (five cases) in the treatment of severely infected diabetic foot, that can be considered a life-threatening condition. In our case reports, patients presented with clinical signs and symptoms of severe sepsis. Our treatment based on multidisciplinary approach (surgical, NPWTid, interventional radiology, skin grafts) had satisfying results. NPWT represented an important support to treatment of these diabetic patients.


Subject(s)
Diabetic Foot/microbiology , Diabetic Foot/therapy , Negative-Pressure Wound Therapy , Diabetic Foot/complications , Humans
4.
G Chir ; 39(3): 184-187, 2018.
Article in English | MEDLINE | ID: mdl-29923490

ABSTRACT

Intussusception is a rare condition in the adult population: it is responsible for 1% of all bowel obstructions. In most of intussusceptions a malignant tumor is involved; a lot of studies show that approximately 50% of malignant metastases causing small bowel intussusception are metastatic melanomas. In present paper a case of a small bowel intussusception probably due to metastases of an occult melanoma, in a 69-year-old patient, is presented. Surgery resection, careful research of possible primitive neoplasms and an accurate follow-up program has been the treatment of choice. All the investigations carried out did not allow to identify a possible primitive neoplasm. The last whole body PET carried out 44 months after surgery resulted disease-free.


Subject(s)
Intussusception/etiology , Jejunal Diseases/etiology , Jejunal Neoplasms/complications , Melanoma/complications , Carcinoma, Squamous Cell , Humans , Jejunal Neoplasms/secondary , Jejunal Neoplasms/surgery , Laryngeal Neoplasms , Lymphatic Metastasis , Male , Melanoma/secondary , Melanoma/surgery , Middle Aged , Neoplasms, Second Primary/complications , Neoplasms, Second Primary/surgery , Neoplasms, Unknown Primary
5.
G Chir ; 36(5): 231-5, 2015.
Article in English | MEDLINE | ID: mdl-26712262

ABSTRACT

BACKGROUND: Merkel cell Carcinoma is a very rare primary cutaneous tumor that often looks like an innocuous and asymptomatic nodule or plaque of the skin, but with a very fast growing. It is also called neuroendocrine carcinoma of the skin or trabecular cancer. The main treatment is based on a local excision followed by radiotherapy or chemotherapy. The most common site of presentation of this lesion is head and neck (40-60%.) and it often occur in older men with immunological system dysfunction like HIV patients, cancer, severe infections and immunosuppression for transplantation. METHODS: The authors report a case of a bleeding Merkel Cell Carcinoma of the right leg in a 83 years old man with HCV infection, chronic kidney disease and diabetes mellitus type 2 that required local excision. RESULTS: Lesion was entirely removed and then patient was sent to oncologists. After two months from surgical excision, healing process is regular and without complications. CONCLUSIONS: This type of tumor can be misdiagnosed and, if bleeding, it can represent a serious surgical emergency.


Subject(s)
Carcinoma, Merkel Cell/pathology , Carcinoma, Merkel Cell/surgery , Hemorrhage , Immunocompromised Host , Renal Insufficiency, Chronic , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Aged, 80 and over , Carcinoma, Merkel Cell/complications , Carcinoma, Merkel Cell/radiotherapy , Diabetes Mellitus, Type 2/complications , Hemorrhage/etiology , Hepatitis C, Chronic/complications , Humans , Hypertension/complications , Leg/pathology , Male , Renal Dialysis/methods , Renal Insufficiency, Chronic/therapy , Risk Factors , Skin Neoplasms/complications , Skin Neoplasms/radiotherapy , Treatment Outcome
6.
Minerva Chir ; 69(4): 225-8, 2014 Aug.
Article in English | MEDLINE | ID: mdl-24987970

ABSTRACT

AIM: This prospective study was done to evaluate the efficacy of commercial fibrin glue application in the healing of patients with fistulas-in-ano from a short follow up period (one year). METHODS: This randomized clinical trial of 26 patients was performed during the period from January 2012 to July 2012. Nineteen men and seven women were treated for a fistula-in-ano with a commercial fibrin glue injection. In the operating room, the patients underwent an anorectal examination under spinal anesthesia. The external and internal fistula tract openings were then identified and the fistula tract was accurately curetted. Fibrin glue was introduced by a loaded double-channel syringe into the external fistula opening until the fibrin glue tip could be seen emerging from the internal opening. RESULTS: The initial success rate was 76.9% (20/26). Recurrence rate was 23% (6/26). Four patients underwent a re-application of fibrin glue and the fistulas of these patients closed. Total recurrence rate was 7.6% (2/26). The overall success rate was 69.2% (18/26). CONCLUSION: Fibrin glue application was thus found to be an easy, safe, successful alternative treatment in the management of fistulas-in-ano. Specifically, this therapeutic option demonstrated his efficacy for simple non-ramificated transsphincteric and intersphincteric fistulas. Multicentric randomized clinical trials with more representative sample seem to be necessary to investigate the best patients to treat by fibrin glue injection and the optimal application technique to improve these results.


Subject(s)
Fibrin Tissue Adhesive/administration & dosage , Rectal Fistula/drug therapy , Tissue Adhesives/administration & dosage , Adult , Colonoscopy , Curettage/methods , Female , Fibrin Tissue Adhesive/therapeutic use , Follow-Up Studies , Humans , Injections, Intralesional , Male , Middle Aged , Prospective Studies , Rectal Fistula/diagnosis , Rectal Fistula/surgery , Recurrence , Risk Assessment , Severity of Illness Index , Time Factors , Tissue Adhesives/therapeutic use , Treatment Outcome
7.
G Chir ; 34(5-6): 173-5, 2013.
Article in English | MEDLINE | ID: mdl-23837958

ABSTRACT

The gastrointestinal tract is the predominant site of extranodal non-Hodgkin lymphomas. Multiple lynphomatous polyposis is a type of appearance of mantle cell lymphoma. It is characterized by multiple polypoid lesions involving long gastrointestinal tracts and it accounts for only approximately 1-2% of non-Hodgkin lymphomas. A 78 years old patient was admitted to our Department of General Surgery with rectal bleeding, abdominal pain and weight loss. Multiple lymphomatous polyposis was detected by endoscopy. Endoscopic biopsies confirmed the diagnosis of mantle cell lymphoma. The patient was transferred to the Department of Hematology for cycles of chemotherapy.


Subject(s)
Gastrointestinal Neoplasms , Lymphoma, Mantle-Cell , Lymphoma, Non-Hodgkin , Neoplasms, Multiple Primary , Polyps , Aged , Gastrointestinal Neoplasms/pathology , Humans , Lymphoma, Mantle-Cell/pathology , Lymphoma, Non-Hodgkin/pathology , Male , Neoplasms, Multiple Primary/pathology , Polyps/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...